(Q61840785)

English

ACTR-56. A 2-PART SAFETY AND EXPLORATORY EFFICACY RANDOMISED DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A 1:1 RATIO OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL (CBD:THC) PLUS DOSE-INTENSE TEMOZOLOMIDE IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIF

article published in 2017

Statements

ACTR-56. A 2-PART SAFETY AND EXPLORATORY EFFICACY RANDOMISED DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A 1:1 RATIO OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL (CBD:THC) PLUS DOSE-INTENSE TEMOZOLOMIDE IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM) (English)
November 2017
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit